Trastuzumab-TKI combination in HER2-Positive tumors: a FAERS-Based safety profile and multimodal analysis of Tanespimycin's role in enhancing targeting of the HSP90AA1-PI3K-Akt-mTOR axis.
Chen X et al. · 2026
NCBI PubMed Central · Papers · License: Open Access · 2026